Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.
Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.
Investigated for use/treatment in alzheimer's disease.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.